Paper · 3907856

Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.

Greider CW and 1 other. Cell, 1985. Cited by 2,620 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Papers, record 3907856. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3907856

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.; PubMed
Journal: Cell; PubMed
Year: 1985; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/3907856/; PubMed
DOI: https://doi.org/10.1016/0092-8674(85)90170-9; PubMed
The journal: https://conductscience.org/library/journal-index/0413066; PubMed
Citations, by iCite: 2,620; iCite
Relative citation ratio, by iCite: 51.2; iCite
Revised in PubMed: 2022-03-31; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Greider CW	C W
2	Blackburn EH	E H

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
DNA Nucleotidylexotransferase	Major topic
DNA Nucleotidyltransferases	Major topic
Tetrahymena	Major topic
Animals
Base Sequence
Chromosomes
DNA Polymerase II
DNA Replication
Models, Genetic
Saccharomyces cerevisiae
Templates, Genetic

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
GM 26259	NIGMS NIH HHS	United States	R01GM026259	PubMed and NIH	NIH RePORTER
			R37GM026259	NIH	NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

Kind	PMID	Title	In Papers	Source
Comment in	14,744,437	Beginning to understand the end of the chromosome.	https://conductscience.org/library/papers/14744437	PubMed
Comment in	15,055,591	Tracking telomerase.	https://conductscience.org/library/papers/15055591	PubMed

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by1,257

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,620 citations.

PMID	Title	Journal	Year	In Papers	Source
42,969,970	Extended DNA damage-induced G2/M arrests lead to aberrant mitoses through accumulation of securin.	J Cell Biol	2026	https://conductscience.org/library/papers/42969970	PubMed
42,905,107	Taming Mre11-Rad50 at Telomeres: Convergent Strategies for Chromosome-End Protection Across Evolution.	Bioessays	2026	https://conductscience.org/library/papers/42905107	PubMed
42,845,463	Single-base substitutions switch RNA tertiary allostery between positive and negative coupling.	bioRxiv	2026	https://conductscience.org/library/papers/42845463	PubMed
42,819,843	Research Progress on Telomerase Activity Assays: From Traditional Methods to Novel Technologies.	ACS Omega	2026	https://conductscience.org/library/papers/42819843	PubMed
42,793,249	The Different Faces of the Selective Human Telomerase Inhibitor: BIBR1532 and Its Derivatives.	Curr Issues Mol Biol	2026	https://conductscience.org/library/papers/42793249	PubMed
42,758,366	An Accessible Approach to Molecular and Biomarker Testing for Risk Stratification in Oral Cavity Squamous Cell Carcinoma.	Head Neck Pathol	2026	https://conductscience.org/library/papers/42758366	PubMed
42,758,105	Telomeres in mitosis: organization and dynamics.	Nucleus	2026	https://conductscience.org/library/papers/42758105	PubMed
42,748,372	Evaluation of Vamana and Virechana as Interventions to Decelerate the Aging Process in Healthy Adult Volunteers: Protocol for an Exploratory Single-Arm Clinical Trial.	JMIR Res Protoc	2026	https://conductscience.org/library/papers/42748372	PubMed
42,682,710	Telomerase expression and activity in the immortal cnidarian Hydra.	Front Cell Dev Biol	2026	https://conductscience.org/library/papers/42682710	PubMed
42,680,848	How telomere attrition protects against cancer.	Nat Rev Genet	2026	https://conductscience.org/library/papers/42680848	PubMed

1 to 10 of 1,257

See all 1,257 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
DNTT	1,791	PubTator's text mining	https://conductscience.org/library/genes/1791

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3907856

GET https://conductscience.org/api/papers/v1/3907856/cited_by?page=2

API reference For AI assistants